BioSurface Engineering Technologies Inc., U.S. Department of Energy’s Brookhaven National Laboratory deal

BioSurface received exclusive worldwide rights to synthetic analogs of two growth factors, including fibroblast growth factor (FGF), for wound healing and radiation protection. The analogs were devel...